Atara Biotherapeutics/ US0465131078 /
2024-06-13 7:06:47 PM | Chg. -0.02 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.53USD | -3.31% | 4,506 Turnover: 2,359.86 |
-Bid Size: - | -Ask Size: - | 0.54 | 0.51 |
GlobeNewswire
2023-09-04
Ipsen nominates Pascal Touchon to its Board of Directors as new independent director
Newsfile Corp
2022-07-27
ATRA INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible ...
GlobeNewswire
2022-03-16
Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Off...
GlobeNewswire
2022-01-26
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Thera...
GlobeNewswire
2021-11-03
180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
GlobeNewswire
2021-10-12
Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
GlobeNewswire
2021-07-12
Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
GlobeNewswire
2021-06-10
Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch
GlobeNewswire
2020-10-21
The Alliance for Regenerative Medicine Announces Election of 2021 Officers, Executive Committee, and...
GlobeNewswire
2020-07-29
The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020 Cell & Gene...
GlobeNewswire
2020-05-07
Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Highlights
GlobeNewswire
2020-04-06
eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications
GlobeNewswire
2020-02-27
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Clini...
GlobeNewswire
2020-02-21
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)